 |
decitabine |
|---|---|
| Trade Name | Dacogen |
| Orphan Indication | Myelodysplastic syndromes |
| USA Market Approval | USA |
| USA Designation Date | 1999-03-08 00:00:00 |
| Sponsor | Otsuka Pharmaceutical Development;and Commercialization, Inc., 508 Carnegie Center Drive;Princeton, New Jersey, 08540 |
